Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 40 entries
Sorted by: Best Match Show Resources per page
Symposium on Parkinson's disease. Introduction.

Primary care

Dejong JD.
PMID: 264218
Prim Care. 1977 Sep;4(3):391-401.

No abstract available.

Cite
Dejong JD. Symposium on Parkinson's disease. Introduction. Prim Care. 1977;4(3):391-401
Dejong, J. D. (1977). Symposium on Parkinson's disease. Introduction. Primary care, 4(3), 391-401.
Dejong, J D. "Symposium on Parkinson's disease. Introduction." Primary care vol. 4,3 (1977): 391-401.
Dejong JD. Symposium on Parkinson's disease. Introduction. Prim Care. 1977 Sep;4(3):391-401. PMID: 264218.
Copy Download .nbib Format: NLM
Easing adjustment to Parkinson's disease.

The American journal of nursing

Fischbach FT.
PMID: 245248
Am J Nurs. 1978 Jan;78(1):66-9.

No abstract available.

Cite
Fischbach FT. Easing adjustment to Parkinson's disease. Am J Nurs. 1978;78(1):66-9
Fischbach, F. T. (1978). Easing adjustment to Parkinson's disease. The American journal of nursing, 78(1), 66-9.
Fischbach, F T. "Easing adjustment to Parkinson's disease." The American journal of nursing vol. 78,1 (1978): 66-9.
Fischbach FT. Easing adjustment to Parkinson's disease. Am J Nurs. 1978 Jan;78(1):66-9. PMID: 245248.
Copy Download .nbib Format: NLM
[Parkinson disease. Etiology, physiopathology, diagnosis, development, treatment].

La Revue du praticien

Fénelon G.
PMID: 8978170
Rev Prat. 1996 Nov 01;46(17):2137-44.

No abstract available.

Cite
Fénelon G. Maladie de Parkinson. Etiologie, physiopathologie, diagnostic, évolution, traitment. [Parkinson disease. Etiology, physiopathology, diagnosis, development, treatment]. Rev Prat. 1996;46(17):2137-44
Fénelon, G. (1996). Maladie de Parkinson. Etiologie, physiopathologie, diagnostic, évolution, traitment. [Parkinson disease. Etiology, physiopathology, diagnosis, development, treatment]. La Revue du praticien, 46(17), 2137-44.
Fénelon, G. "Maladie de Parkinson. Etiologie, physiopathologie, diagnostic, évolution, traitment." [Parkinson disease. Etiology, physiopathology, diagnosis, development, treatment]. La Revue du praticien vol. 46,17 (1996): 2137-44.
Fénelon G. Maladie de Parkinson. Etiologie, physiopathologie, diagnostic, évolution, traitment. [Parkinson disease. Etiology, physiopathology, diagnosis, development, treatment]. Rev Prat. 1996 Nov 01;46(17):2137-44. French. PMID: 8978170.
Copy Download .nbib Format: NLM
Diagnosis of PD.

Neurology

Rajput AH.
PMID: 8351036
Neurology. 1993 Aug;43(8):1629-30. doi: 10.1212/wnl.43.8.1629-b.

No abstract available.

Cite
Rajput AH. Diagnosis of PD. Neurology. 1993;43(8):1629-30doi: 10.1212/wnl.43.8.1629-b.
Rajput, A. H. (1993). Diagnosis of PD. Neurology, 43(8), 1629-30. https://doi.org/10.1212/wnl.43.8.1629-b
Rajput, A H. "Diagnosis of PD." Neurology vol. 43,8 (1993): 1629-30. doi: https://doi.org/10.1212/wnl.43.8.1629-b
Rajput AH. Diagnosis of PD. Neurology. 1993 Aug;43(8):1629-30. doi: 10.1212/wnl.43.8.1629-b. PMID: 8351036.
Copy Download .nbib Format: NLM
Drug holiday and management of Parkinson disease.

Neurology

Cordingley G.
PMID: 6889711
Neurology. 1982 Oct;32(10):1205-6. doi: 10.1212/wnl.32.10.1205.

No abstract available.

Cite
Cordingley G. Drug holiday and management of Parkinson disease. Neurology. 1982;32(10):1205-6doi: 10.1212/wnl.32.10.1205.
Cordingley, G. (1982). Drug holiday and management of Parkinson disease. Neurology, 32(10), 1205-6. https://doi.org/10.1212/wnl.32.10.1205
Cordingley, G. "Drug holiday and management of Parkinson disease." Neurology vol. 32,10 (1982): 1205-6. doi: https://doi.org/10.1212/wnl.32.10.1205
Cordingley G. Drug holiday and management of Parkinson disease. Neurology. 1982 Oct;32(10):1205-6. doi: 10.1212/wnl.32.10.1205. PMID: 6889711.
Copy Download .nbib Format: NLM
Dementia with Lewy bodies.

The Medical clinics of North America

Leverenz JB, McKeith IG.
PMID: 12171059
Med Clin North Am. 2002 May;86(3):519-35. doi: 10.1016/s0025-7125(02)00012-3.

DLB is a complex disorder with important associations with PD and AD. As clinicians, it is important for us to identify these patients because of their unique responses to medical interventions and to help patients and caregivers more fully...

Cite
Leverenz JB, McKeith IG. Dementia with Lewy bodies. Med Clin North Am. 2002;86(3):519-35doi: 10.1016/s0025-7125(02)00012-3.
Leverenz, J. B., & McKeith, I. G. (2002). Dementia with Lewy bodies. The Medical clinics of North America, 86(3), 519-35. https://doi.org/10.1016/s0025-7125(02)00012-3
Leverenz, James B, and McKeith, Ian G. "Dementia with Lewy bodies." The Medical clinics of North America vol. 86,3 (2002): 519-35. doi: https://doi.org/10.1016/s0025-7125(02)00012-3
Leverenz JB, McKeith IG. Dementia with Lewy bodies. Med Clin North Am. 2002 May;86(3):519-35. doi: 10.1016/s0025-7125(02)00012-3. PMID: 12171059.
Copy Download .nbib Format: NLM
A preliminary report on the measurement of Parkinson's disease.

Neurology

BURNS BD, DEJONG JD.
PMID: 13689185
Neurology. 1960 Dec;10:1096-102. doi: 10.1212/wnl.10.12.1096.

No abstract available.

Cite
BURNS BD, DEJONG JD. A preliminary report on the measurement of Parkinson's disease. Neurology. 1960;10:1096-102doi: 10.1212/wnl.10.12.1096.
BURNS, B. D., & DEJONG, J. D. (1960). A preliminary report on the measurement of Parkinson's disease. Neurology, 101096-102. https://doi.org/10.1212/wnl.10.12.1096
BURNS, B D, and DEJONG, J D. "A preliminary report on the measurement of Parkinson's disease." Neurology vol. 10 (1960): 1096-102. doi: https://doi.org/10.1212/wnl.10.12.1096
BURNS BD, DEJONG JD. A preliminary report on the measurement of Parkinson's disease. Neurology. 1960 Dec;10:1096-102. doi: 10.1212/wnl.10.12.1096. PMID: 13689185.
Copy Download .nbib Format: NLM
Deep brain stimulation in early stage Parkinson's disease may reduce the relative risk of symptom worsening.

Parkinsonism & related disorders

Hacker M, Charles D, Finder S.
PMID: 26639979
Parkinsonism Relat Disord. 2016 Jan;22:112-3. doi: 10.1016/j.parkreldis.2015.11.023. Epub 2015 Nov 25.

No abstract available.

Cite
Hacker M, Charles D, Finder S. Deep brain stimulation in early stage Parkinson's disease may reduce the relative risk of symptom worsening. Parkinsonism Relat Disord. 2015;22:112-3doi: 10.1016/j.parkreldis.2015.11.023.
Hacker, M., Charles, D., & Finder, S. (2016). Deep brain stimulation in early stage Parkinson's disease may reduce the relative risk of symptom worsening. Parkinsonism & related disorders, 22112-3. https://doi.org/10.1016/j.parkreldis.2015.11.023
Hacker, Mallory, et al. "Deep brain stimulation in early stage Parkinson's disease may reduce the relative risk of symptom worsening." Parkinsonism & related disorders vol. 22 (2016): 112-3. doi: https://doi.org/10.1016/j.parkreldis.2015.11.023
Hacker M, Charles D, Finder S. Deep brain stimulation in early stage Parkinson's disease may reduce the relative risk of symptom worsening. Parkinsonism Relat Disord. 2016 Jan;22:112-3. doi: 10.1016/j.parkreldis.2015.11.023. Epub 2015 Nov 25. PMID: 26639979.
Copy Download .nbib Format: NLM
Science to practice: Imaging tools to study cognition in Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

Strafella AP, Burn D.
PMID: 24338679
Mov Disord. 2014 Mar;29(3):283-4. doi: 10.1002/mds.25769. Epub 2013 Dec 11.

No abstract available.

Cite
Strafella AP, Burn D. Science to practice: Imaging tools to study cognition in Parkinson's disease. Mov Disord. 2013;29(3):283-4doi: 10.1002/mds.25769.
Strafella, A. P., & Burn, D. (2014). Science to practice: Imaging tools to study cognition in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 29(3), 283-4. https://doi.org/10.1002/mds.25769
Strafella, Antonio P, and Burn, David. "Science to practice: Imaging tools to study cognition in Parkinson's disease." Movement disorders : official journal of the Movement Disorder Society vol. 29,3 (2014): 283-4. doi: https://doi.org/10.1002/mds.25769
Strafella AP, Burn D. Science to practice: Imaging tools to study cognition in Parkinson's disease. Mov Disord. 2014 Mar;29(3):283-4. doi: 10.1002/mds.25769. Epub 2013 Dec 11. PMID: 24338679.
Copy Download .nbib Format: NLM
[No title available]

Presse medicale (Paris, France : 1983)

Azulay JP, Tranchant C.
PMID: 28325375
Presse Med. 2017 Mar;46(2):174. doi: 10.1016/j.lpm.2017.02.001.

No abstract available.

Cite
Azulay JP, Tranchant C. Éditorial. . Presse Med. 2017;46(2):174doi: 10.1016/j.lpm.2017.02.001.
Azulay, J. P., & Tranchant, C. (2017). Éditorial. . Presse medicale (Paris, France : 1983), 46(2), 174. https://doi.org/10.1016/j.lpm.2017.02.001
Azulay, Jean-Philippe, and Tranchant, Christine. "Éditorial." . Presse medicale (Paris, France : 1983) vol. 46,2 (2017): 174. doi: https://doi.org/10.1016/j.lpm.2017.02.001
Azulay JP, Tranchant C. Éditorial. . Presse Med. 2017 Mar;46(2):174. doi: 10.1016/j.lpm.2017.02.001. French. PMID: 28325375.
Copy Download .nbib Format: NLM
Doctor--how quickly will my Parkinson's progress?.

European journal of neurology

Fox SH, Ceravolo R.
PMID: 24995513
Eur J Neurol. 2015 Mar;22(3):421-2. doi: 10.1111/ene.12502. Epub 2014 Jul 03.

No abstract available.

Cite
Fox SH, Ceravolo R. Doctor--how quickly will my Parkinson's progress?. Eur J Neurol. 2014;22(3):421-2doi: 10.1111/ene.12502.
Fox, S. H., & Ceravolo, R. (2015). Doctor--how quickly will my Parkinson's progress?. European journal of neurology, 22(3), 421-2. https://doi.org/10.1111/ene.12502
Fox, S H, and Ceravolo, R. "Doctor--how quickly will my Parkinson's progress?." European journal of neurology vol. 22,3 (2015): 421-2. doi: https://doi.org/10.1111/ene.12502
Fox SH, Ceravolo R. Doctor--how quickly will my Parkinson's progress?. Eur J Neurol. 2015 Mar;22(3):421-2. doi: 10.1111/ene.12502. Epub 2014 Jul 03. PMID: 24995513.
Copy Download .nbib Format: NLM
Abolishing the 1-year rule: How much evidence will be enough?.

Movement disorders : official journal of the Movement Disorder Society

Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G.
PMID: 27666574
Mov Disord. 2016 Nov;31(11):1623-1627. doi: 10.1002/mds.26796. Epub 2016 Sep 26.

No abstract available.

Cite
Postuma RB, Berg D, Stern M, et al. Abolishing the 1-year rule: How much evidence will be enough?. Mov Disord. 2016;31(11):1623-1627doi: 10.1002/mds.26796.
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Marek, K., Litvan, I., Lang, A. E., Halliday, G., Goetz, C. G., Gasser, T., Dubois, B., Chan, P., Bloem, B. R., Adler, C. H., & Deuschl, G. (2016). Abolishing the 1-year rule: How much evidence will be enough?. Movement disorders : official journal of the Movement Disorder Society, 31(11), 1623-1627. https://doi.org/10.1002/mds.26796
Postuma, Ronald B, et al. "Abolishing the 1-year rule: How much evidence will be enough?." Movement disorders : official journal of the Movement Disorder Society vol. 31,11 (2016): 1623-1627. doi: https://doi.org/10.1002/mds.26796
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. Abolishing the 1-year rule: How much evidence will be enough?. Mov Disord. 2016 Nov;31(11):1623-1627. doi: 10.1002/mds.26796. Epub 2016 Sep 26. PMID: 27666574.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 40 entries